4//SEC Filing
OConnell Daniel Joseph 4
Accession 0001628280-26-001895
CIK 0001576885other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 6:50 PM ET
Size
9.3 KB
Accession
0001628280-26-001895
Insider Transaction Report
Form 4
OConnell Daniel Joseph
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-01-08$1.82/sh−8,143$14,815→ 611,839 total - Sale
Common Stock
[F1][F3]2026-01-09$1.76/sh−12,941$22,832→ 598,898 total - Sale
Common Stock
[F1][F4]2026-01-12$1.73/sh−5,388$9,307→ 593,510 total
Footnotes (4)
- [F1]Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 27, 2025.
- [F2]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7200 to $1.8700. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7100 to $1.8100. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.6700 to $1.8400. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Derek Meisner, Attorney-in-Fact|2026-01-12
Documents
Issuer
Acumen Pharmaceuticals, Inc.
CIK 0001576885
Entity typeother
Related Parties
1- filerCIK 0001865136
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 6:50 PM ET
- Size
- 9.3 KB